title: Therapeutic modulators of STAT signalling for human diseases.
abstract: The signal transducer and activator of transcription (STAT) proteins have important roles in biological processes. The abnormal activation of STAT signalling pathways is also implicated in many human diseases, including cancer, autoimmune diseases, rheumatoid arthritis, asthma and diabetes. Over a decade has passed since the first inhibitor of a STAT protein was reported and efforts to discover modulators of STAT signalling as therapeutics continue. This Review discusses the outcomes of the ongoing drug discovery research endeavours against STAT proteins, provides perspectives on new directions for accelerating the discovery of drug candidates, and highlights the noteworthy candidate therapeutics that have progressed to clinical trials.
authors.affiliation: Cancer Biology, and Natural Products and Experimental Therapeutics Programs, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, Hawaii 96813, USA.
authors.forename: Gabriella
authors.initials: G
authors.lastname: Miklossy
authors.forename: Tyvette S
authors.initials: TS
authors.lastname: Hilliard
authors.forename: James
authors.initials: J
authors.lastname: Turkson
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D004194:Disease; D055808:Drug Discovery / Q000379:methods*; D015507:Drugs, Investigational / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008958:Models, Molecular; D058990:Molecular Targeted Therapy / Q000379:methods*; D050791:STAT Transcription Factors / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*; D054852:Small Molecule Libraries; D013329:Structure-Activity Relationship
chemical_list: D015507:Drugs, Investigational; D050791:STAT Transcription Factors; D054852:Small Molecule Libraries
references.citation: Anticancer Res. 2010 Feb;30(2):429-37
references.pmid: 20332450
references.citation: Science. 1994 Sep 16;265(5179):1701-6
references.pmid: 8085155
references.citation: Cancer Biol Ther. 2011 Nov 1;12(9):837-45
references.pmid: 21885917
references.citation: Invest New Drugs. 2012 Jun;30(3):916-26
references.pmid: 21340507
references.citation: Mol Pharmacol. 2010 Nov;78(5):903-8
references.pmid: 20693278
references.citation: Development. 2007 Aug;134(15):2739-50
references.pmid: 17611223
references.citation: J Cell Physiol. 2012 May;227(5):2184-95
references.pmid: 21792937
references.citation: N Engl J Med. 2008 Jul 24;359(4):378-90
references.pmid: 18650514
references.citation: Mol Cancer. 2012 Mar 16;11:12
references.pmid: 22423663
references.citation: Br J Pharmacol. 2010 Oct;161(3):541-54
references.pmid: 20880395
references.citation: Cancer Cell. 2009 Dec 8;16(6):487-97
references.pmid: 19962667
references.citation: Cancer. 2011 Jul 1;117(13):2970-85
references.pmid: 21225866
references.citation: Int J Oncol. 2009 Jan;34(1):25-32
references.pmid: 19082474
references.citation: Mol Nutr Food Res. 2009 Jan;53(1):115-28
references.pmid: 19072742
references.citation: J Med Chem. 2000 Nov 2;43(22):4233-46
references.pmid: 11063620
references.citation: Eur J Med Chem. 2013 Apr;62:498-507
references.pmid: 23416191
references.citation: Bioorg Med Chem. 2009 Oct 1;17(19):6926-36
references.pmid: 19747833
references.citation: Clin Transl Oncol. 2011 Mar;13(3):179-84
references.pmid: 21421462
references.citation: J Immunol. 2007 Aug 15;179(4):2556-64
references.pmid: 17675518
references.citation: Lancet Oncol. 2009 Jan;10(1):25-34
references.pmid: 19095497
references.citation: Inflamm Res. 2005 Oct;54(10):395-411
references.pmid: 16283107
references.citation: Cancer Res. 1999 Oct 15;59(20):5059-63
references.pmid: 10537273
references.citation: Am J Respir Crit Care Med. 2006 Jun 1;173(11):1216-21
references.pmid: 16528019
references.citation: Biopolymers. 2008;90(1):69-79
references.pmid: 18058821
references.citation: Cancer Biol Ther. 2012 Nov;13(13):1255-61
references.pmid: 22895078
references.citation: J Biol Chem. 2010 Nov 12;285(46):35855-65
references.pmid: 20807764
references.citation: ACS Med Chem Lett. 2010 Jul 13;1(8):371-5
references.pmid: 24900220
references.citation: Bioorg Med Chem. 2008 Jul 1;16(13):6509-21
references.pmid: 18534856
references.citation: PLoS One. 2012;7(2):e30820
references.pmid: 22319590
references.citation: Oncogene. 2004 May 13;23(22):3999-4006
references.pmid: 15007386
references.citation: Science. 1997 Sep 12;277(5332):1630-5
references.pmid: 9287210
references.citation: J Cancer Res Clin Oncol. 2010 Apr;136(4):603-10
references.pmid: 19816711
references.citation: J Med Chem. 2005 Oct 20;48(21):6661-70
references.pmid: 16220982
references.citation: Cancer Res. 2010 Mar 15;70(6):2445-54
references.pmid: 20215512
references.citation: Biochem Biophys Res Commun. 2009 May 1;382(2):445-50
references.pmid: 19285962
references.citation: Am J Respir Cell Mol Biol. 2009 Feb;40(2):159-67
references.pmid: 18688040
references.citation: Mol Cancer Ther. 2004 Mar;3(3):261-9
references.pmid: 15026546
references.citation: Cancer Prev Res (Phila). 2012 May;5(5):726-34
references.pmid: 22401982
references.citation: Stem Cells. 1999;17(3):138-46
references.pmid: 10342556
references.citation: Mol Oncol. 2012 Oct;6(5):484-93
references.pmid: 22717603
references.citation: Int J Mol Sci. 2012;13(5):6236-45
references.pmid: 22754361
references.citation: Clin Cancer Res. 2013 Apr 15;19(8):1933-40
references.pmid: 23406773
references.citation: Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9623-8
references.pmid: 22623533
references.citation: Clin Exp Pharmacol Physiol. 2009 Apr;36(4):373-9
references.pmid: 19018808
references.citation: Br J Pharmacol. 2013 Feb;168(3):658-72
references.pmid: 22978563
references.citation: Drug Discov Ther. 2012 Apr;6(2):94-101
references.pmid: 22622019
references.citation: Nucleic Acid Ther. 2013 Jun;23(3):213-27
references.pmid: 23692080
references.citation: J Biol Chem. 2001 Nov 30;276(48):45443-55
references.pmid: 11579100
references.citation: Cancer Prev Res (Phila). 2012 Feb;5(2):205-15
references.pmid: 22030090
references.citation: Oncogene. 2000 May 15;19(21):2474-88
references.pmid: 10851046
references.citation: J Exp Med. 1998 Dec 7;188(11):2067-74
references.pmid: 9841920
references.citation: Mol Cancer Ther. 2011 Mar;10(3):481-94
references.pmid: 21216930
references.citation: Annu Rev Immunol. 2003;21:713-58
references.pmid: 12500979
references.citation: BMC Cancer. 2011 Mar 28;11:112
references.pmid: 21443800
references.citation: Clin Cancer Res. 2012 Sep 15;18(18):4986-96
references.pmid: 22825581
references.citation: J Pharmacol Exp Ther. 2012 May;341(2):410-23
references.pmid: 22328572
references.citation: J Exp Ther Oncol. 2012;10(2):155-62
references.pmid: 23350355
references.citation: Circulation. 2007 Jun 12;115(23):2939-47
references.pmid: 17533179
references.citation: J Exp Med. 2011 Aug 1;208(8):1635-48
references.pmid: 21727188
references.citation: Oncogene. 2000 May 15;19(21):2566-76
references.pmid: 10851055
references.citation: Mol Pharmacol. 2007 May;71(5):1435-43
references.pmid: 17325127
references.citation: Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7239-44
references.pmid: 9207075
references.citation: Evid Based Complement Alternat Med. 2012;2012:952762
references.pmid: 22272214
references.citation: N Engl J Med. 2013 Jan 10;368(2):161-70
references.pmid: 23301733
references.citation: J Hematol Oncol. 2011 Feb 07;4:6
references.pmid: 21299849
references.citation: EMBO J. 1999 Sep 1;18(17):4657-68
references.pmid: 10469645
references.citation: Int J Cancer. 2004 Feb 20;108(5):665-71
references.pmid: 14696092
references.citation: J Neurooncol. 2012 May;107(3):487-501
references.pmid: 22249692
references.citation: Expert Opin Ther Targets. 2004 Oct;8(5):409-22
references.pmid: 15469392
references.citation: Cancer Res. 2006 Jun 1;66(11):5542-8
references.pmid: 16740687
references.citation: Blood. 2003 Jan 1;101(1):134-42
references.pmid: 12393707
references.citation: Cancer Lett. 2013 Jul 10;335(1):145-52
references.pmid: 23402820
references.citation: Ann N Y Acad Sci. 2011 Jan;1215:150-60
references.pmid: 21261654
references.citation: N Engl J Med. 2012 May 17;366(20):1905-13
references.pmid: 22591296
references.citation: Leuk Res. 2007 Jan;31(1):91-5
references.pmid: 16828865
references.citation: Proc Natl Acad Sci U S A. 2007 May 1;104(18):7391-6
references.pmid: 17463090
references.citation: J Immunol. 1998 Nov 1;161(9):4652-60
references.pmid: 9794394
references.citation: Int J Cancer. 2011 Nov 15;129(10):2502-11
references.pmid: 21207415
references.citation: J Cell Physiol. 2012 Mar;227(3):976-93
references.pmid: 21503893
references.citation: Oncogene. 2002 Mar 27;21(13):2000-8
references.pmid: 11960372
references.citation: Mol Cancer. 2010 Aug 16;9:217
references.pmid: 20712901
references.citation: J Med Chem. 2011 May 26;54(10):3549-63
references.pmid: 21486047
references.citation: Cell Physiol Biochem. 2011;28(2):219-28
references.pmid: 21865729
references.citation: PLoS One. 2012;7(8):e40724
references.pmid: 22899991
references.citation: Carcinogenesis. 2007 Aug;28(8):1780-7
references.pmid: 17557905
references.citation: ACS Med Chem Lett. 2010 May 13;1(2):85-89
references.pmid: 20596242
references.citation: ACS Chem Biol. 2007 Dec 21;2(12):787-98
references.pmid: 18154266
references.citation: PLoS One. 2012;7(8):e30207
references.pmid: 22879872
references.citation: Carcinogenesis. 2010 Nov;31(11):1991-8
references.pmid: 20724373
references.citation: Biochim Biophys Acta. 2011 Feb;1812(2):246-51
references.pmid: 20600875
references.citation: PLoS One. 2012;7(4):e35513
references.pmid: 22530037
references.citation: Cancer Res. 2013 Mar 15;73(6):1922-33
references.pmid: 23322008
references.citation: J Antibiot (Tokyo). 2003 Jun;56(6):513-9
references.pmid: 12931859
references.citation: Immunity. 2012 Apr 20;36(4):503-14
references.pmid: 22520844
references.citation: Mutat Res. 2012 Jan-Mar;750(1):60-82
references.pmid: 22108298
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4700-5
references.pmid: 15781862
references.citation: Mol Cancer Res. 2007 Sep;5(9):943-55
references.pmid: 17855663
references.citation: Cancer Lett. 2010 Jun 28;292(2):197-207
references.pmid: 20053498
references.citation: Leuk Res. 2011 Feb;35(2):243-9
references.pmid: 20542334
references.citation: DNA Cell Biol. 2011 Feb;30(2):71-8
references.pmid: 21091189
references.citation: Lung Cancer. 2013 May;80(2):120-30
references.pmid: 23384674
references.citation: Mol Cancer Ther. 2010 Apr;9(4):953-62
references.pmid: 20371721
references.citation: Cancer Res. 2011 Nov 1;71(21):6601-10
references.pmid: 21920898
references.citation: Cancer Biol Ther. 2012 Jul;13(9):766-75
references.pmid: 22801507
references.citation: J Biol Chem. 2010 Oct 22;285(43):33520-33529
references.pmid: 20720018
references.citation: J Clin Invest. 2001 Sep;108(5):739-47
references.pmid: 11544280
references.citation: J Mol Med (Berl). 2011 Jul;89(7):713-27
references.pmid: 21465181
references.citation: Cancer Biol Ther. 2012 May;13(7):534-41
references.pmid: 22406995
references.citation: Neoplasia. 2012 Jun;14(6):509-18
references.pmid: 22787432
references.citation: Eur J Biochem. 2001 Sep;268(17):4809-14
references.pmid: 11532018
references.citation: Cancer Prev Res (Phila). 2012 Apr;5(4):631-43
references.pmid: 22369852
references.citation: Cancer Chemother Pharmacol. 2009 Mar;63(4):681-9
references.pmid: 18587580
references.citation: Nat Med. 2005 Dec;11(12):1314-21
references.pmid: 16288283
references.citation: Mol Cancer Ther. 2011 Dec;10(12):2384-93
references.pmid: 22027691
references.citation: Scand J Infect Dis. 2013 Mar;45(3):235-8
references.pmid: 22992060
references.citation: Biochem Biophys Res Commun. 2012 Oct 12;427(1):24-9
references.pmid: 22982675
references.citation: Blood. 2010 Sep 23;116(12):2070-7
references.pmid: 20466853
references.citation: Cell. 1996 Feb 9;84(3):431-42
references.pmid: 8608597
references.citation: Bioorg Med Chem Lett. 2007 Apr 1;17(7):1875-8
references.pmid: 17336521
references.citation: Int J Oncol. 2011 May;38(5):1245-52
references.pmid: 21369699
references.citation: Clin Cancer Res. 2002 Apr;8(4):945-54
references.pmid: 11948098
references.citation: Int Immunopharmacol. 2010 Jan;10(1):18-25
references.pmid: 19796711
references.citation: Br J Pharmacol. 2011 Nov;164(5):1506-21
references.pmid: 21506956
references.citation: PLoS One. 2012;7(5):e37960
references.pmid: 22662257
references.citation: Cancer Res. 2003 Mar 15;63(6):1270-9
references.pmid: 12649187
references.citation: Kidney Int. 2011 Feb;79(4):452-63
references.pmid: 20980973
references.citation: N Engl J Med. 2007 Oct 18;357(16):1608-19
references.pmid: 17881745
references.citation: J Clin Oncol. 2009 Sep 10;27(26):4422-32
references.pmid: 19667270
references.citation: PLoS One. 2012;7(8):e43711
references.pmid: 22937084
references.citation: Cancer Lett. 2013 Jan 28;328(2):243-51
references.pmid: 23032719
references.citation: Cancer Res. 2011 Jun 1;71(11):3831-40
references.pmid: 21512135
references.citation: Blood. 2008 Dec 15;112(13):5095-102
references.pmid: 18824601
references.citation: Br J Cancer. 2005 Jul 11;93(1):70-80
references.pmid: 15970928
references.citation: Int J Cancer. 2010 Jul 15;127(2):282-92
references.pmid: 19937797
references.citation: Mol Cancer Ther. 2007 Mar;6(3):987-94
references.pmid: 17363492
references.citation: Chem Biol. 2006 Nov;13(11):1235-42
references.pmid: 17114005
references.citation: Cancer Res. 2009 Jan 1;69(1):193-202
references.pmid: 19118003
references.citation: PLoS One. 2009;4(3):e4783
references.pmid: 19274102
references.citation: Br J Cancer. 2009 Jan 13;100(1):106-12
references.pmid: 19127268
references.citation: Bioorg Med Chem Lett. 2003 Feb 24;13(4):633-6
references.pmid: 12639546
references.citation: Int J Oncol. 2008 Jan;32(1):89-95
references.pmid: 18097546
references.citation: Mol Oncol. 2012 Jun;6(3):276-83
references.pmid: 22387217
references.citation: Biochem Pharmacol. 2010 May 15;79(10):1398-409
references.pmid: 20067773
references.citation: Exp Mol Med. 2008 Oct 31;40(5):514-22
references.pmid: 18985009
references.citation: J Invest Dermatol. 2008 Nov;128(11):2728-2735
references.pmid: 18496567
references.citation: J Gastrointest Oncol. 2013 Mar;4(1):72-81
references.pmid: 23451330
references.citation: Oncogene. 2000 Dec 27;19(56):6613-26
references.pmid: 11426647
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):5998-6003
references.pmid: 15837920
references.citation: Lipids Health Dis. 2011 Dec 16;10:236
references.pmid: 22177381
references.citation: Invest New Drugs. 2011 Oct;29(5):818-26
references.pmid: 20372971
references.citation: Blood Cancer J. 2011 Dec;1(12):e46
references.pmid: 22829094
references.citation: Folia Biol (Praha). 2007;53(1):1-6
references.pmid: 17328836
references.citation: Oncogene. 2000 May 15;19(21):2468-73
references.pmid: 10851045
references.citation: Nat Med. 2005 Jun;11(6):595-6
references.pmid: 15937466
references.citation: BMC Cancer. 2010 May 10;10:187
references.pmid: 20459702
references.citation: N Engl J Med. 2011 Jul 7;365(1):54-61
references.pmid: 21714643
references.citation: Mol Cancer Ther. 2004 Oct;3(10):1183-91
references.pmid: 15486184
references.citation: J Hepatol. 2011 Nov;55(5):1041-8
references.pmid: 21354226
references.citation: Nat Rev Cancer. 2004 Feb;4(2):97-105
references.pmid: 14964307
references.citation: Mol Cancer Ther. 2007 Apr;6(4):1400-5
references.pmid: 17431118
references.citation: Expert Opin Investig Drugs. 2009 Jan;18(1):45-56
references.pmid: 19053881
references.citation: Clin Cancer Res. 2010 May 1;16(9):2550-61
references.pmid: 20388845
references.citation: Cancer Prev Res (Phila). 2011 Feb;4(2):230-7
references.pmid: 21163936
references.citation: Braz J Med Biol Res. 1998 Jan;31(1):55-60
references.pmid: 9686179
references.citation: J Immunol. 2008 Jul 15;181(2):1491-8
references.pmid: 18606704
references.citation: Mol Oncol. 2013 Jun;7(3):369-78
references.pmid: 23206899
references.citation: Oncogene. 1996 Jul 18;13(2):247-54
references.pmid: 8710363
references.citation: Immunopharmacol Immunotoxicol. 2011 Dec;33(4):714-22
references.pmid: 22053946
references.citation: Clin Cancer Res. 2010 May 1;16(9):2571-9
references.pmid: 20388852
references.citation: N Engl J Med. 2010 Jun 17;362(24):2260-70
references.pmid: 20525995
references.citation: PLoS One. 2013 May 21;8(5):e63697
references.pmid: 23704931
references.citation: Clin Exp Allergy. 2011 Nov;41(11):1622-30
references.pmid: 22093011
references.citation: Cancer Chemother Pharmacol. 2009 May;63(6):983-95
references.pmid: 18766340
references.citation: J Skin Cancer. 2013;2013:684050
references.pmid: 23577258
references.citation: Cardiovasc Res. 2008 Sep 1;79(4):698-705
references.pmid: 18511434
references.citation: Anticancer Drugs. 2005 Jul;16(6):601-7
references.pmid: 15930886
references.citation: Mol Cancer Res. 2009 Jan;7(1):118-28
references.pmid: 19147543
references.citation: Cancer Discov. 2012 Aug;2(8):694-705
references.pmid: 22719020
references.citation: Childs Nerv Syst. 2012 Mar;28(3):363-73
references.pmid: 22249380
references.citation: Br J Pharmacol. 2011 May;163(2):283-98
references.pmid: 21198544
references.citation: Bioorg Med Chem. 2012 Jan 15;20(2):750-8
references.pmid: 22217933
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3801-4
references.pmid: 9108058
references.citation: Biochem Biophys Res Commun. 2008 Dec 26;377(4):1232-7
references.pmid: 18996091
references.citation: Eur J Med Chem. 2013 Feb;60:112-9
references.pmid: 23287056
references.citation: Immunology. 2007 Dec;122(4):607-14
references.pmid: 17645497
references.citation: BMC Immunol. 2011 Aug 31;12:51
references.pmid: 21884580
references.citation: J Invest Dermatol. 2006 Jun;126(6):1396-402
references.pmid: 16614726
references.citation: J Immunol. 2010 Mar 15;184(6):3186-90
references.pmid: 20147633
references.citation: Cancer Res. 2006 Oct 1;66(19):9714-21
references.pmid: 17018630
references.citation: Curr Mol Med. 2008 Aug;8(5):384-92
references.pmid: 18691065
references.citation: Bioorg Med Chem Lett. 2013 Apr 1;23(7):2225-9
references.pmid: 23434226
references.citation: Chembiochem. 2008 Mar 25;9(5):723-7
references.pmid: 18247434
references.citation: Eur J Pharmacol. 2010 Sep 1;641(1):15-22
references.pmid: 20483353
references.citation: Blood. 2010 Apr 15;115(15):3109-17
references.pmid: 20130243
references.citation: Eur J Med Chem. 2012 Sep;55:220-7
references.pmid: 22871485
references.citation: Am J Respir Cell Mol Biol. 2009 Nov;41(5):516-24
references.pmid: 19202006
references.citation: In Vivo. 2009 Mar-Apr;23(2):237-43
references.pmid: 19414409
references.citation: J Immunol. 2011 Feb 15;186(4):2571-83
references.pmid: 21242523
references.citation: Cancer Prev Res (Phila). 2010 Apr;3(4):495-504
references.pmid: 20233899
references.citation: Nat Med. 2004 Jan;10(1):48-54
references.pmid: 14702634
references.citation: Bioorg Med Chem Lett. 2008 Sep 15;18(18):4988-92
references.pmid: 18768317
references.citation: Arthritis Res Ther. 2006;8(1):R17
references.pmid: 16507120
references.citation: Prostate. 2012 Jan;72(1):82-9
references.pmid: 21538419
references.citation: Clin Cancer Res. 2006 Dec 1;12(23):7140-8
references.pmid: 17145839
references.citation: Blood. 2011 Mar 24;117(12):3421-9
references.pmid: 21233313
references.citation: Oncotarget. 2011 Jun;2(6):518-24
references.pmid: 21680956
references.citation: Carcinogenesis. 2010 Dec;31(12):2097-104
references.pmid: 20732905